| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2460 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2125 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 716 | 2021 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 436 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 325 | 2021 |
| Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana VC Harris, G Armah, S Fuentes, KE Korpela, U Parashar, JC Victor, J Tate, ... The Journal of infectious diseases 215 (1), 34-41, 2017 | 281 | 2017 |
| Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan V Harris, A Ali, S Fuentes, K Korpela, M Kazi, J Tate, U Parashar, ... Gut Microbes 9 (2), 93-101, 2018 | 155 | 2018 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients R Koning, P Bastard, JL Casanova, MC Brouwer, D van de Beek Intensive care medicine 47, 704-706, 2021 | 109 | 2021 |
| Effect of antibiotic-mediated microbiome modulation on rotavirus vaccine immunogenicity: a human, randomized-control proof-of-concept trial VC Harris, BW Haak, SA Handley, B Jiang, DE Velasquez, BL Hykes, ... Cell host & microbe 24 (2), 197-207. e4, 2018 | 105 | 2018 |
| Clinical features and prognostic factors in Covid-19: a prospective cohort study S de Bruin, LD Bos, MA van Roon, AM Tuip-de Boer, AR Schuurman, ... EBioMedicine 67, 2021 | 92 | 2021 |
| Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and nonhospitalized patients with COVID-19 EH Vogelzang, FC Loeff, NIL Derksen, S Kruithof, P Ooijevaar-de Heer, ... The Journal of Immunology 205 (12), 3491-3499, 2020 | 80 | 2020 |
| Effect of co-infection with intestinal parasites on COVID-19 severity: a prospective observational cohort study D Wolday, T Gebrecherkos, ZG Arefaine, YK Kiros, A Gebreegzabher, ... EClinicalMedicine 39, 2021 | 78 | 2021 |
| The intestinal microbiome in infectious diseases: the clinical relevance of a rapidly emerging field VC Harris, BW Haak, M Boele van Hensbroek, WJ Wiersinga Open forum infectious diseases 4 (3), ofx144, 2017 | 76 | 2017 |
| Chest CT in the emergency department for diagnosis of COVID-19 pneumonia: Dutch experience S Schalekamp, CP Bleeker-Rovers, LFM Beenen, ... Radiology 298 (2), E98-E106, 2021 | 73 | 2021 |
| The complex interactions between rotavirus and the gut microbiota AHJ Kim, MP Hogarty, VC Harris, MT Baldridge Frontiers in cellular and infection microbiology 10, 586751, 2021 | 49 | 2021 |
| Microbiota regulation of viral infections through interferon signaling NI Wirusanti, MT Baldridge, VC Harris Trends in microbiology 30 (8), 778-792, 2022 | 47 | 2022 |
| Mutations of complement lectin pathway genes MBL2 and MASP2 associated with placental malaria V Holmberg, P Onkamo, E Lahtela, P Lahermo, G Bedu-Addo, ... Malaria journal 11, 1-9, 2012 | 40 | 2012 |
| Added value of chest computed tomography in suspected COVID-19: an analysis of 239 patients DA Korevaar, RS Kootte, LP Smits, JG van den Aardweg, PI Bonta, ... European Respiratory Journal 56 (2), 2020 | 34 | 2020 |
| Indoleamine 2, 3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19 L Guo, B Schurink, E Roos, EJ Nossent, JW Duitman, APJ Vlaar, ... The Journal of pathology 256 (3), 256-261, 2022 | 32 | 2022 |
